700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Research Article Open Access
This exploratory, descriptive study aims to explore general practitioners’ viewpoint about biosimilar drugs, conducted on a sample of 128 randomly selected general practitioners serving in public sector hospitals in Karachi, Pakistan. They were surveyed with a 12 items questionnaire that evaluates their approach towards biosimilar drugs. The collected data was analyzed for frequency distributions and χ2 using SPSS. The present findings highlight a need for further education of physicians and others related to the prescribing of biosimilar medicines as poor knowledge could result in serious medication errors, adverse events or a delay in desired therapeutic gain for the patient. Further dialogue and collaboration between physicians, authorities and healthcare biotech industry should be continued on a priority basis.
Biosimilar drugs, General practitioners, Healthcare biotech industry, Pakistan, Differential Diagnosis, Laboratory Diagnosis, Medical Diagnosis